r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

GL

Gary A. Lyons

Insider · Director · TVTX

Gary A. Lyons files insider transactions with the SEC as a director of Travere Therapeutics (TVTX). We hold 3 disclosed purchases and sales filed since 23 January 2006, 2 of them in the last 90 days.

  • Files forTVTX
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure19 August 2026

Positions held

15 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 14 May 2021 — 18 August 2026Director · Travere Therapeutics (TVTX)28 Form 4 lines · source: SEC Form 4
  • Filed 19 January 2006 — 27 May 2026President and CEO · Neurocrine Biosciences (NBIX)107 Form 4 lines · source: SEC Form 4
  • Filed 31 May 2006 — 26 May 2023Director · Rigel Pharmaceuticals (RIGL)21 Form 4 lines · source: SEC Form 4
  • Filed 1 February 2022 — 1 May 2023Director · Eledon Pharmaceuticals (ELDN)3 Form 4 lines · source: SEC Form 4
  • Filed 14 February 2020 — 17 May 2022Director · Brickell Biotech (BBI)36 Form 4 lines · source: SEC Form 4
  • Filed 30 June 2017 — 11 September 2020Director · Novus Therapeutics (NVUS)4 Form 4 lines · source: SEC Form 4
  • Filed 8 October 2014 — 15 May 2020Director · Retrophin (RTRX)14 Form 4 lines · source: SEC Form 4
  • Filed 19 May 2006 — 23 May 2018Director · Vical (VICL)22 Form 4 lines · source: SEC Form 4
  • Filed 26 January 2017 — 28 November 2017Director · Cytori Therapeutics (CTYX)4 Form 4 lines · source: SEC Form 4
  • Filed 7 October 2013 — 15 June 2016Director · Cytori Therapeutics (CYTX)9 Form 4 lines · source: SEC Form 4
  • Filed 30 April 2013 — 10 July 2015Director · Kalobios Pharmaceuticals (KBIO)3 Form 4 lines · source: SEC Form 4
  • Filed 27 April 2011 — 7 June 2012Director · NeurogesX (NGSX)3 Form 4 lines · source: SEC Form 4
  • Filed 7 July 2009 — 11 July 2011Director · Poniard Pharmaceuticals (PARD)9 Form 4 lines · source: SEC Form 4
  • Filed 23 January 2009 — 21 April 2010Director · Facet Biotech (FACT)8 Form 4 lines · source: SEC Form 4
  • Filed 16 July 2008 — 13 August 2008Director · Pdl Biopharma (PDLI)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.